Detalhe da pesquisa
1.
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial.
Lancet Oncol
; 14(8): 777-86, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23782814
2.
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: a multicenter phase II study.
Oncology
; 85(1): 44-52, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23838576
3.
Capecitabine-based chemoradiotherapy with adjuvant capecitabine for locally advanced squamous carcinoma of the uterine cervix: phase II results.
Oncologist
; 14(8): 828-34, 2009 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-19661184
4.
Randomized, placebo-controlled, phase II study of sequential erlotinib and chemotherapy as first-line treatment for advanced non-small-cell lung cancer.
J Clin Oncol
; 27(30): 5080-7, 2009 Oct 20.
Artigo
Inglês
| MEDLINE | ID: mdl-19738125